Physician

Joseph Lee Mitchell, M.D.

According to 2025 Medicare claims, Joseph Mitchell, M.D. (NPI: 1952669152) practices geriatric medicine in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Louis, MO. This provider's primary affiliated billing organization is EMPOWERME MEDICAL GROUP, PC (NPI: 1811682107; TIN: 923035678) and primary practice location at 63144-1872.

Mitchell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 906 traditional Medicare patients, billed 3,288 HCPCS/CPT codes, and received $606,436 in Medicare payments. The top billing code was G0523 (Management of a new patient with dementia, moderate to high complexity, for use in cmmi model). Part D data shows 331 prescription claims across 59 beneficiaries totaling $25,424 in drug costs, led by Quetiapine Fumarate (Quetiapine Fumarate). 2022 DME data shows 54 claims. Open Payments data shows 1 records totaling $18. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $4,165 to $606,436. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $51,788 and ending at $25,424. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $762 to $1,883.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	40	147	$4,165
2017	169	881	$19,499
2018	271	1,693	$38,039
2019	420	2,596	$69,505
2020	355	2,636	$64,260
2021	457	3,043	$73,371
2022	113	591	$12,721
2023	N/R	N/R	N/R
2024	906	3,288	$606,436

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	118	971	$51,788
2016	70	328	$19,737
2017	71	228	$135,631
2018	80	399	$361,163
2019	145	413	$200,378
2020	120	273	$68,390
2021	136	311	$97,453
2022	50	126	$28,129
2023	32	87	$5,490
2024	59	331	$25,424

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$463
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	14	14	$2,985
2020	N/R	N/R	N/R
2021	16	29	$3,853
2022	N/R	54	$1,475
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0523	Management of a new patient with dementia, moderate to high complexity, for use in cmmi model	455	1,076	$374
G0522	Management of a new patient with dementia, low complexity, for use in cmmi model	168	405	$220
99344	Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes	149	149	$112
99426	Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month	191	602	$49
99427	Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month	173	879	$37

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Quetiapine Fumarate	Quetiapine Fumarate	17	419	$329
Pravastatin Sodium	Pravastatin Sodium	11	294	$242
Donepezil Hcl	Donepezil Hcl	11	294	$185
Sertraline Hcl	Sertraline Hcl	16	448	$125
Atorvastatin Calcium	Atorvastatin Calcium	11	308	$59

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$18	Neurocrine Biosciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph Lee Mitchell, M.D.?

Tedicare shows public-source Medicare data for Joseph Lee Mitchell, M.D. (NPI 1952669152), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph Lee Mitchell, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joseph Lee Mitchell, M.D.?

Joseph Lee Mitchell, M.D. is linked to EMPOWERME MEDICAL GROUP, PC (billing NPI 1811682107) in the available physician profile data.

Does Joseph Lee Mitchell, M.D. have Open Payments data?

Joseph Lee Mitchell, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.